DEFA14A: Unicycive Therapeutics Announces Time Change for 2025 Annual Meeting of Stockholders

Sentiment:

8-K Filing


Unicycive Therapeutics announced a change in the time of its 2025 Annual Meeting of Stockholders, while the date and location remain the same.

Summary

  • Unicycive Therapeutics, Inc. announced a change in the time of the 2025 Annual Meeting of Stockholders.
  • The meeting will still be held on June 9, 2025, at 4300 El Camino Real, Suite 210, Los Altos, CA 94022.
  • The time has been changed to 7:00 a.m., Pacific Daylight Time.
  • Stockholders of record as of April 30, 2025, can find additional details regarding participation in the Annual Meeting.

Sentiment

Score: 5

Explanation: The document is a neutral announcement about a change in meeting time, with no inherent positive or negative sentiment.

Future Outlook

The document does not contain any specific forward-looking statements regarding financial performance or future business prospects beyond the details of the annual meeting.

Management Comments

  • Shalabh Gupta, Chief Executive Officer, signed the report on behalf of Unicycive Therapeutics, Inc.

Industry Context

This announcement is a routine corporate update regarding the logistics of the company's annual meeting. It doesn't provide insights into the competitive landscape or broader industry trends in biotechnology or kidney disease treatments.

Key Dates

DateDescription
April 30, 2025Record date for stockholders eligible to participate in the Annual Meeting
May 21, 2025Date of the announcement regarding the time change for the Annual Meeting
June 9, 2025Date of the Annual Meeting of Stockholders, now scheduled for 7:00 a.m. Pacific Daylight Time

Keywords

Annual Meeting, Stockholders, Unicycive Therapeutics, Time Change, Kidney Disease, Biotechnology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.